Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation

Finding robust biomarkers for Parkinson disease (PD) is currently hampered by inherent technical limitations associated with imaging or antibody-based protein assays. To circumvent the challenges, we adapted a staged pipeline, starting from our previous proteomic profiling followed by high-throughpu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Cell Proteomics
Auteurs principaux: Shi, Min, Movius, James, Dator, Romel, Aro, Patrick, Zhao, Yanchun, Pan, Catherine, Lin, Xiangmin, Bammler, Theo K., Stewart, Tessandra, Zabetian, Cyrus P., Peskind, Elaine R., Hu, Shu-Ching, Quinn, Joseph F., Galasko, Douglas R., Zhang, Jing
Format: Artigo
Langue:Inglês
Publié: The American Society for Biochemistry and Molecular Biology 2015
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349976/
https://ncbi.nlm.nih.gov/pubmed/25556233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M114.040576
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires